{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:49:26Z","timestamp":1785876566844,"version":"3.56.0"},"reference-count":74,"publisher":"Elsevier","isbn-type":[{"value":"9780443345258","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.irn.2026.05.010","type":"book-chapter","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:58:34Z","timestamp":1779911914000},"page":"1-32","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic therapeutic targets in Alzheimer\u2019s disease"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3165-8802","authenticated-orcid":false,"given":"Ignatius Raymond","family":"Peter L","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4333-2333","authenticated-orcid":false,"given":"Debojyoti","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4886-1792","authenticated-orcid":false,"given":"A. Froilanmark","family":"Chrishone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7691-5704","authenticated-orcid":false,"given":"Dileep","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.irn.2026.05.010_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2025.100400","article-title":"FDG-PET brain glucose hypometabolism predicts Alzheimer\u2019s disease progression pathways in cognitively normal adults: A longitudinal competing risks modeling","author":"Alhasan","year":"2025","journal-title":"Metabolism Open"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.010_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12017-025-08832-6","article-title":"The conceivable role of metabolic syndrome in the pathogenesis of Alzheimer\u2019s disease: Cellular and subcellular alterations in underpinning a tale of two","volume":"27","author":"Alzarea","year":"2025","journal-title":"Neuromolecular Medicine"},{"key":"10.1016\/bs.irn.2026.05.010_bib3","unstructured":"Alzheimer\u2019s Society. (2025, March 19). Researching new drugs for Alzheimer\u2019s disease. https:\/\/www.alzheimers.org.uk\/what-we-do\/researchers\/news\/researching-new-drugs-alzheimers-disease."},{"issue":"6","key":"10.1016\/bs.irn.2026.05.010_bib4","first-page":"617","article-title":"Expression of beta-secretase mRNA in transgenic Tg2576 mouse brain and its modulation by metabolic conditions","volume":"107","author":"Bigl","year":"2000","journal-title":"Journal of Neural Transmission"},{"issue":"15","key":"10.1016\/bs.irn.2026.05.010_bib5","first-page":"1605","article-title":"Insulin: An emerging treatment for Alzheimer\u2019s disease dementia?","volume":"73","author":"Burns","year":"2013","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.010_bib6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","article-title":"Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nature Reviews. Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.010_bib7","first-page":"673","article-title":"Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer\u2019s disease","volume":"20","author":"Butterfield","year":"2010","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"15","key":"10.1016\/bs.irn.2026.05.010_bib8","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.3390\/nu14153231","article-title":"Supplementation with NAD+ and its precursors to prevent cognitive decline across disease contexts","volume":"14","author":"Campbell","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/bs.irn.2026.05.010_bib9","doi-asserted-by":"crossref","first-page":"1430465","DOI":"10.3389\/fnins.2024.1430465","article-title":"New insights in lipid metabolism: Potential therapeutic targets for the treatment of Alzheimer\u2019s disease","volume":"18","author":"Cao","year":"2024","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.irn.2026.05.010_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnut.2016.00031","article-title":"Putative role of red wine polyphenols against brain pathology in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"3","author":"Caruana","year":"2016","journal-title":"Frontiers in Nutrition"},{"key":"10.1016\/bs.irn.2026.05.010_bib11","doi-asserted-by":"crossref","unstructured":"Correas, A. G., Olaso-Gonzalez, G., Roca, M., Blanco-Gand\u00eda, M. C., Nascimento, C., Lahoz, A., ... & Vi\u00f1a, J. (2024). Glucose 6 phosphate dehydrogenase overexpression rescues the loss of cognition in the double transgenic APP\/PS1 mouse model of Alzheimer\u2019s disease. Redox Biology, 75, 103242.","DOI":"10.1016\/j.redox.2024.103242"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.010_bib12","article-title":"Hypometabolism as a therapeutic target in Alzheimer\u2019s disease","volume":"9","author":"Costantini","year":"2008","journal-title":"BMC Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.010_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment","volume":"69","author":"Craft","year":"2012","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.irn.2026.05.010_bib14","article-title":"Effects of intranasal insulin and empagliflozin on cognition and brain health in early Alzheimer\u2019s disease: A randomized clinical trial","author":"Craft","year":"2025","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"11","key":"10.1016\/bs.irn.2026.05.010_bib15","first-page":"5324","article-title":"Targeting immunometabolic pathways for combination therapy in Alzheimer\u2019s disease","volume":"19","author":"Craft","year":"2023","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"8","key":"10.1016\/bs.irn.2026.05.010_bib16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40263-024-01103-1","article-title":"Alzheimer\u2019s disease: Combination therapies and clinical trials for combination therapy development","volume":"38","author":"Cummings","year":"2024","journal-title":"CNS Drugs"},{"issue":"15","key":"10.1016\/bs.irn.2026.05.010_bib17","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s40265-023-01938-w","article-title":"Alzheimer\u2019s disease: Novel targets and investigational drugs for disease modification","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.010_bib18","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2007.02.029","article-title":"Alzheimer\u2019s disease-type neuronal tau hyperphosphorylation induced by A\u03b2 oligomers","volume":"29","author":"De Felice","year":"2008","journal-title":"Neurobiology of aging"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.010_bib19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer\u2019s disease is type 3 diabetes\u2014evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"Journal of Diabetes Science and Technology"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.010_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1474-9726.2010.00548.x","article-title":"Aging and disease: Connections to sirtuins","volume":"9","author":"Donmez","year":"2010","journal-title":"Aging Cell"},{"issue":"7","key":"10.1016\/bs.irn.2026.05.010_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073330","article-title":"Ghavami Alzheimer\u2019s disease pathogenesis: Role of autophagy and mitophagy focusing in microglia","volume":"22","author":"Eshraghi","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.010_bib22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/ijms23020786","article-title":"Metabolic syndrome: Updates on pathophysiology and management in 2021","volume":"23","author":"Fahed","year":"2022","journal-title":"International journal of molecular sciences"},{"issue":"700","key":"10.1016\/bs.irn.2026.05.010_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo2984","article-title":"Gut microbiome composition may be an indicator of preclinical Alzheimer\u2019s disease","volume":"15","author":"Ferreiro","year":"2023","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.irn.2026.05.010_bib24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jns.2016.04.042","article-title":"Peripheral arterial endothelial dysfunction of neurodegenerative diseases","volume":"366","author":"Fukui","year":"2016","journal-title":"Journal of the Neurological Sciences"},{"issue":"32","key":"10.1016\/bs.irn.2026.05.010_bib25","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1039\/D0TB01248C","article-title":"Finely tuned Prussian blue-based nanoparticles and their application in disease treatment","volume":"8","author":"Gao","year":"2020","journal-title":"Journal of Materials Chemistry B"},{"key":"10.1016\/bs.irn.2026.05.010_bib26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fnagi.2016.00108","article-title":"Alzheimer\u2019s disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: Randomized, placebo-controlled, double-blind clinical trial","volume":"8","author":"Gejl","year":"2016","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/bs.irn.2026.05.010_bib27","article-title":"Sirtuins promote brain homeostasis, preventing Alzheimer\u2019s disease through targeting neuroinflammation","volume":"13","author":"Grabowska","year":"2022","journal-title":"Frontiers in Physiology"},{"issue":"12","key":"10.1016\/bs.irn.2026.05.010_bib28","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1093\/brain\/awad303","article-title":"Microbiota from Alzheimer\u2019s patients induce deficits in cognition and hippocampal neurogenesis","volume":"146","author":"Grabrucker","year":"2023","journal-title":"Brain"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.010_bib29","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tcm.2015.10.004","article-title":"Metabolic syndrome update","volume":"26","author":"Grundy","year":"2016","journal-title":"Trends in Cardiovascular Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.010_bib30","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: A nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"8","key":"10.1016\/bs.irn.2026.05.010_bib31","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.4103\/NRR.NRR-D-23-01403","article-title":"Decoding molecular mechanisms: brain aging and Alzheimer\u2019s disease","volume":"20","author":"Hayat","year":"2025","journal-title":"Neural Regeneration Research"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.010_bib32","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2174\/157015911798376325","article-title":"Impact and therapeutic potential of PPARs in Alzheimer\u2019s disease","volume":"9","author":"Heneka","year":"2015","journal-title":"Current Neuropharmacology"},{"issue":"8","key":"10.1016\/bs.irn.2026.05.010_bib33","doi-asserted-by":"crossref","first-page":"E1876","DOI":"10.1073\/pnas.1718819115","article-title":"NAD+ supplementation normalizes key Alzheimer\u2019s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency","volume":"115","author":"Hou","year":"2018","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/bs.irn.2026.05.010_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/npjamd.2016.17","article-title":"It takes two to tango: NAD+ and sirtuins in aging\/longevity control","volume":"2","author":"Imai","year":"2016","journal-title":"NPJ Aging and Mechanisms of Disease"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.010_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1507\/endocrj.EJ19-0313","article-title":"Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men","volume":"67","author":"Irie","year":"2020","journal-title":"Endocrine Journal"},{"key":"10.1016\/bs.irn.2026.05.010_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/flang.2023.1199107","article-title":"Defying syntactic preservation in Alzheimer\u2019s disease: What type of impairment predicts syntactic change in dementia (if it does) and why?","volume":"2","author":"Ivanova","year":"2023","journal-title":"Frontiers in Language Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.010_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4149\/endo_2014_01_35","article-title":"Glucose transport in brain\u2014effect of inflammation","volume":"48","author":"Jurcovicova","year":"2014","journal-title":"Endocrine Regulations"},{"key":"10.1016\/bs.irn.2026.05.010_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/bs.irn.2020.03.015","article-title":"Brain glucose and ketone utilization in brain aging and neurodegenerative diseases","volume":"154","author":"Kapogiannis","year":"2020","journal-title":"International Review of Neurobiology"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.010_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2015.3","article-title":"Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome","volume":"47","author":"Kim","year":"2015","journal-title":"Experimental & Molecular Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.010_bib40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5056\/jnm18087","article-title":"Brain-gut-microbiota axis in Alzheimer\u2019s disease","volume":"25","author":"Kowalski","year":"2019","journal-title":"Journal of Neurogastroenterology and Motility"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.010_bib41","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1\u03b1","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"key":"10.1016\/bs.irn.2026.05.010_bib42","article-title":"Mediterranean diet and Alzheimer\u2019s disease","volume":"3","author":"Lange","year":"2019","journal-title":"Movement and Nutrition in Health and Disease"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.010_bib43","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.mcna.2007.06.012","article-title":"Insulin resistance as the underlying cause for the metabolic syndrome","volume":"91","author":"Lann","year":"2007","journal-title":"Medical Clinics of North America"},{"key":"10.1016\/bs.irn.2026.05.010_bib44","article-title":"The role of AMPK\u03b1 subunit in Alzheimer\u2019s disease: In-depth analysis and future prospects","volume":"99","author":"Li","year":"2024","journal-title":"Ageing Research Reviews"},{"issue":"9","key":"10.1016\/bs.irn.2026.05.010_bib45","first-page":"6464","article-title":"The link between gut microbiome and Alzheimer\u2019s disease: From the perspective of new revised criteria for diagnosis and staging of Alzheimer\u2019s disease","volume":"20","author":"Liang","year":"2024","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.010_bib46","first-page":"491","article-title":"Deficient glucose transporters in Alzheimer\u2019s disease brain","volume":"14","author":"Liu","year":"2008","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.010_bib47","first-page":"1301","article-title":"Therapeutic potential of AMP-activated protein kinase in Alzheimer\u2019s disease","volume":"68","author":"Ma","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/bs.irn.2026.05.010_bib48","doi-asserted-by":"crossref","unstructured":"Mandal, P., Trushina, E., Arnold, M., Kaddurah-Daouk, R., & Baloni, P. (2025). Mitochondrial bioenergetic signatures differentiate asymptomatic from symptomatic Alzheimer\u2019s disease. bioRxiv, 2025\u201311. https:\/\/doi.org\/10.1101\/2025.11.04.686626.","DOI":"10.1101\/2025.11.04.686626"},{"issue":"23","key":"10.1016\/bs.irn.2026.05.010_bib49","doi-asserted-by":"crossref","first-page":"9299","DOI":"10.3390\/ijms21239299","article-title":"Cellular consequences of coenzyme Q10 deficiency in neurodegeneration of the retina and brain","volume":"21","author":"Manzar","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"44","key":"10.1016\/bs.irn.2026.05.010_bib50","doi-asserted-by":"crossref","first-page":"15703","DOI":"10.1523\/JNEUROSCI.0552-11.2011","article-title":"The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer\u2019s disease","volume":"31","author":"McManus","year":"2011","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2026.05.010_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1400544","article-title":"Neurotoxic \u03b2-amyloid oligomers cause mitochondrial dysfunction\u2014The trigger for PANoptosis in neurons","volume":"16","author":"Meng","year":"2024","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2026.05.010_bib52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s42255-023-00756-4","article-title":"Loss of fatty acid degradation by astrocytic mitochondria triggers neuroinflammation and neurodegeneration","volume":"5","author":"Mi","year":"2023","journal-title":"Nature Metabolism"},{"key":"10.1016\/bs.irn.2026.05.010_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40336-013-0026-y","article-title":"Glucose metabolism in normal aging and Alzheimer\u2019s disease: Methodological and physiological considerations for PET studies","volume":"1","author":"Mosconi","year":"2013","journal-title":"Clinical and Translational Imaging"},{"key":"10.1016\/bs.irn.2026.05.010_bib54","first-page":"132","article-title":"Hypometabolism and cognitive decline in Alzheimer\u2019s disease","volume":"35","author":"Mosconi","year":"2008","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"6","key":"10.1016\/bs.irn.2026.05.010_bib55","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/antiox8060177","article-title":"Suppression of AMD-like pathology by mitochondria-targeted antioxidant SkQ1 is associated with a decrease in the accumulation of amyloid \u03b2 and in mTOR activity","volume":"8","author":"Muraleva","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/bs.irn.2026.05.010_bib56","unstructured":"National Institute on Aging. (2024). Beyond the brain: The gut microbiome and Alzheimer\u2019s disease. https:\/\/www.nia.nih.gov\/news\/beyond-brain-gut-microbiome-and-alzheimers-disease."},{"issue":"3","key":"10.1016\/bs.irn.2026.05.010_bib57","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3390\/molecules28031168","article-title":"Neuroprotective effect of \u03b1-lipoic acid against A\u03b225\u201335-induced damage in BV2 cells","volume":"28","author":"Pei","year":"2023","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.010_bib58","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","article-title":"SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function","volume":"15","author":"Price","year":"2012","journal-title":"Cell Metabolism"},{"key":"10.1016\/bs.irn.2026.05.010_bib59","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fendo.2018.00400","article-title":"The therapeutic potential of metformin in neurodegenerative diseases","volume":"9","author":"Rotermund","year":"2018","journal-title":"Frontiers in Endocrinology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.010_bib60","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/ADR-200166","article-title":"Sildenafil for the treatment of Alzheimer\u2019s disease: A systematic review","volume":"4","author":"Sanders","year":"2020","journal-title":"Journal of Alzheimer\u2019s Disease Reports"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.010_bib61","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s12276-023-01146-2","article-title":"Current understanding of the Alzheimer\u2019s disease-associated microbiome and therapeutic strategies","volume":"56","author":"Seo","year":"2024","journal-title":"Experimental & Molecular Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.010_bib62","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s12035-024-04335-w","article-title":"Nicotinamide riboside restores nicotinamide adenine dinucleotide levels and alleviates brain injury by inhibiting oxidative stress and neuroinflammation in a mouse model of intracerebral hemorrhage","volume":"62","author":"She","year":"2025","journal-title":"Molecular Neurobiology"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.010_bib63","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/jcm9010126","article-title":"Back to the fusion: mitofusin-2 in Alzheimer\u2019s disease","volume":"9","author":"Sita","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.010_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/hbm.70180","article-title":"Relationships between brain glucose metabolism patterns and impaired glycemic status: A systematic review of FDG\u2010PET studies with a focus on Alzheimer\u2019s disease","volume":"46","author":"Soltani","year":"2025","journal-title":"Human Brain Mapping"},{"issue":"1","key":"10.1016\/bs.irn.2026.05.010_bib65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"4","key":"10.1016\/bs.irn.2026.05.010_bib66","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients","volume":"122","author":"Talbot","year":"2012","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/bs.irn.2026.05.010_bib67","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cmet.2011.10.002","article-title":"Calorie restriction-like effects of resveratrol in humans","volume":"14","author":"Timmers","year":"2012","journal-title":"Cell Metabolism"},{"key":"10.1016\/bs.irn.2026.05.010_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1484373","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: A key frontier for future targeted therapies","volume":"15","author":"Wang","year":"2025","journal-title":"Frontiers in Immunology"},{"issue":"18","key":"10.1016\/bs.irn.2026.05.010_bib69","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.3390\/cells11182849","article-title":"A role for PGC-1a in the control of abnormal mitochondrial dynamics in Alzheimer\u2019s disease","volume":"11","author":"Wang","year":"2022","journal-title":"Cells"},{"issue":"8","key":"10.1016\/bs.irn.2026.05.010_bib70","first-page":"1247","article-title":"GLUT1 reductions exacerbate Alzheimer\u2019s disease vascular and metabolic dysfunction","volume":"35","author":"Winkler","year":"2015","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10.1016\/bs.irn.2026.05.010_bib71","doi-asserted-by":"crossref","first-page":"530219","DOI":"10.3389\/fnins.2020.530219","article-title":"Metabolic dysregulation contributes to the progression of Alzheimer\u2019s disease","volume":"14","author":"Yan","year":"2020","journal-title":"Frontiers in neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.010_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108952","article-title":"Mitochondrial biogenesis in developing astrocytes regulates astrocyte maturation and synapse formation","volume":"35","author":"Zehnder","year":"2021","journal-title":"Cell Reports"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.010_bib74","first-page":"310","article-title":"Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice","volume":"5","author":"Zhang","year":"2025","journal-title":"Nature Aging"},{"issue":"2","key":"10.1016\/bs.irn.2026.05.010_bib75","first-page":"287","article-title":"Blood-brain barrier dysfunction in Alzheimer\u2019s disease: Mechanisms and therapeutic approaches","volume":"119","author":"Zhao","year":"2009","journal-title":"Journal of Clinical Investigation"}],"container-title":["International Review of Neurobiology","Brain Energy Metabolism in Alzheimers Disease - Part C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:19:08Z","timestamp":1785874748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774226000383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443345258"],"references-count":74,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2026.05.010","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}